AbbVie, Inc. (ABBV)
230.11
-2.24
(-0.96%)
USD |
NYSE |
Mar 06, 16:00
229.00
-1.11
(-0.48%)
After-Hours: 20:00
AbbVie SG&A Expense (TTM) : 14.01B for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amgen, Inc. | 7.05B |
| Biogen, Inc. | 2.434B |
| Gilead Sciences, Inc. | 8.398B |
| Johnson & Johnson | 23.68B |
| Eli Lilly & Co. | 11.09B |